Division of General Internal Medicine, Boston University School of Medicine, Boston, MA.
Pulmonary Center, Boston University School of Medicine, Boston, MA; Center for Healthcare Organization and Implementation Research, ENRM VA Hospital, Bedford, MA.
Chest. 2020 Oct;158(4):1734-1741. doi: 10.1016/j.chest.2020.04.062. Epub 2020 May 16.
To address the burden of tobacco use in underserved populations, our safety net hospital developed a tobacco treatment intervention consisting of an "opt-out" electronic health record-based best practice alert + order set, which triggers consultation to an inpatient tobacco treatment consult (TTC) service for all hospitalized smokers.
We sought to understand if the intervention would increase patient-level outcomes (receipt of tobacco treatment during hospitalization and at discharge; 6-month smoking abstinence) and improve hospital-wide performance on tobacco treatment metrics.
We conducted two retrospective quasi-experimental analyses to examine effectiveness of the TTC service. Using a pragmatic design and multivariable logistic regression, we compared patient-level outcomes of receipt of nicotine replacement therapy and 6-month quit rates between smokers seen by the service (n = 505) and eligible smokers not seen because of time constraints (n = 680) between July 2016 and December 2016. In addition, we conducted an interrupted time series analysis to examine the effect of the TTC service on hospital-level performance measures, comparing reported Joint Commission measure rates for inpatient (Tob-2) and postdischarge (Tob-3) tobacco treatment preimplementation (January 2015-June 2016) vs postimplementation (July 2016-December 2017) of the intervention.
Compared with inpatient smokers not seen by the TTC service, smokers seen by the TTC service had higher odds of receiving nicotine replacement during hospitalization (260 of 505 [51.5%] vs 244 of 680 [35.9%]; adjusted ORs [AOR], 1.93 [95% CI, 1.5-2.45]) and at discharge (164 of 505 [32.5%] vs 84 of 680 [12.4%]; AOR, 3.41 [95% CI, 2.54-4.61]), as well as higher odds of 6-month smoking abstinence (75 of 505 [14.9%] vs 68 of 680 [10%]; AOR, 1.48 [95% CI, 1.03-2.12]). Hospital-wide, the intervention was associated with a change in slope trends for Tob-3 (P < .01), but not for Tob-2.
The "opt-out" electronic health record-based TTC service at our large safety net hospital was effective at improving both patient-level outcomes and hospital-level performance metrics, and could be implemented at other safety net hospitals that care for hard-to-reach smokers.
为了减轻弱势人群的烟草使用负担,我们的社区医疗服务中心开发了一种烟草治疗干预措施,包括“退出”电子健康记录为基础的最佳实践警报+医嘱集,该措施会为所有住院吸烟者触发住院烟草治疗咨询(TTC)服务的咨询。
我们想了解该干预措施是否会提高患者层面的结果(住院期间和出院时接受烟草治疗;6 个月的吸烟戒断),并改善医院范围内的烟草治疗指标。
我们进行了两项回顾性准实验分析,以评估 TTC 服务的效果。采用实用设计和多变量逻辑回归,我们比较了接受 TTC 服务的吸烟者(n=505)和因时间限制而未接受服务的符合条件的吸烟者(n=680)在接受尼古丁替代疗法和 6 个月戒烟率方面的患者层面结果。此外,我们进行了一项中断时间序列分析,以检查 TTC 服务对医院层面绩效指标的影响,比较了该干预措施实施前后(2016 年 7 月至 2017 年 12 月)联合委员会报告的住院(Tob-2)和出院后(Tob-3)烟草治疗的报告率。
与未接受 TTC 服务的住院吸烟者相比,接受 TTC 服务的吸烟者在住院期间(505 例中有 260 例[51.5%],680 例中有 244 例[35.9%];调整后的比值比[AOR],1.93[95%CI,1.5-2.45])和出院时(505 例中有 164 例[32.5%],680 例中有 84 例[12.4%];AOR,3.41[95%CI,2.54-4.61])接受尼古丁替代疗法的可能性更高,6 个月吸烟戒断的可能性也更高(505 例中有 75 例[14.9%],680 例中有 68 例[10%];AOR,1.48[95%CI,1.03-2.12])。在医院范围内,该干预措施与 Tob-3 的斜率趋势变化(P<0.01)有关,但与 Tob-2 无关。
我们的大型社区医疗服务中心的“退出”电子健康记录为基础的 TTC 服务在提高患者层面的结果和医院层面的绩效指标方面是有效的,并且可以在为难以接触的吸烟者提供服务的其他社区医疗服务中心实施。